ZA967873B - 2-Cyano-3-mercaptocrotonamides - Google Patents
2-Cyano-3-mercaptocrotonamidesInfo
- Publication number
- ZA967873B ZA967873B ZA967873A ZA967873A ZA967873B ZA 967873 B ZA967873 B ZA 967873B ZA 967873 A ZA967873 A ZA 967873A ZA 967873 A ZA967873 A ZA 967873A ZA 967873 B ZA967873 B ZA 967873B
- Authority
- ZA
- South Africa
- Prior art keywords
- alkyl
- substd
- opt
- halo
- alkoxy
- Prior art date
Links
- YYVQSQHNEJLJDX-ARJAWSKDSA-N (z)-2-cyano-3-sulfanylbut-2-enamide Chemical class C\C(S)=C(/C#N)C(N)=O YYVQSQHNEJLJDX-ARJAWSKDSA-N 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 11
- 125000005843 halogen group Chemical group 0.000 abstract 8
- 125000003545 alkoxy group Chemical group 0.000 abstract 6
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 6
- 125000004438 haloalkoxy group Chemical group 0.000 abstract 4
- 125000001188 haloalkyl group Chemical group 0.000 abstract 4
- 125000003342 alkenyl group Chemical group 0.000 abstract 2
- 125000005842 heteroatom Chemical group 0.000 abstract 2
- 125000000896 monocarboxylic acid group Chemical group 0.000 abstract 2
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 abstract 1
- DBTDEFJAFBUGPP-UHFFFAOYSA-N Methanethial Chemical compound S=C DBTDEFJAFBUGPP-UHFFFAOYSA-N 0.000 abstract 1
- JCXJVPUVTGWSNB-UHFFFAOYSA-N Nitrogen dioxide Chemical compound O=[N]=O JCXJVPUVTGWSNB-UHFFFAOYSA-N 0.000 abstract 1
- 125000004390 alkyl sulfonyl group Chemical group 0.000 abstract 1
- 125000004414 alkyl thio group Chemical group 0.000 abstract 1
- 125000000304 alkynyl group Chemical group 0.000 abstract 1
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 abstract 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 abstract 1
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 abstract 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 abstract 1
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 1
- 125000000816 ethylene group Chemical group [H]C([H])([*:1])C([H])([H])[*:2] 0.000 abstract 1
- 235000019256 formaldehyde Nutrition 0.000 abstract 1
- 125000004995 haloalkylthio group Chemical group 0.000 abstract 1
- 125000000623 heterocyclic group Chemical group 0.000 abstract 1
- -1 methylenedioxyphenyl Chemical group 0.000 abstract 1
- 125000001624 naphthyl group Chemical group 0.000 abstract 1
- 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
- C07D295/182—Radicals derived from carboxylic acids
- C07D295/185—Radicals derived from carboxylic acids from aliphatic carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
- C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
- C07C323/60—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton with the carbon atom of at least one of the carboxyl groups bound to nitrogen atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Dermatology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Rheumatology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pain & Pain Management (AREA)
- Virology (AREA)
- Transplantation (AREA)
- Gastroenterology & Hepatology (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19534649A DE19534649A1 (de) | 1995-09-19 | 1995-09-19 | 2-Cyano-3-mercaptocrotonsäureamide |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA967873B true ZA967873B (en) | 1997-03-19 |
Family
ID=7772520
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA967873A ZA967873B (en) | 1995-09-19 | 1996-09-18 | 2-Cyano-3-mercaptocrotonamides |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US5714514A (enExample) |
| EP (1) | EP0764637B1 (enExample) |
| JP (1) | JPH09132560A (enExample) |
| AT (1) | ATE181730T1 (enExample) |
| AU (1) | AU709499B2 (enExample) |
| CA (1) | CA2185850A1 (enExample) |
| DE (2) | DE19534649A1 (enExample) |
| DK (1) | DK0764637T3 (enExample) |
| ES (1) | ES2135145T3 (enExample) |
| GR (1) | GR3030981T3 (enExample) |
| IL (1) | IL119256A (enExample) |
| MX (1) | MX9604158A (enExample) |
| ZA (1) | ZA967873B (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0123571D0 (en) | 2001-04-05 | 2001-11-21 | Aventis Pharm Prod Inc | Use of (Z)-2-cyano-3-hydroxy-but-2-enoic acid-(4'-trifluoromethylphenyl)-amide for treating multiple sclerosis |
| DE60238999D1 (de) * | 2001-09-26 | 2011-03-03 | Pfizer Italia Srl | Aminoindazolderivate mit kinaseinhibierender wirkung, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen |
| US8389032B2 (en) * | 2005-05-23 | 2013-03-05 | Kraft Foods Global Brands Llc | Delivery system for active components as part of an edible composition having selected particle size |
-
1995
- 1995-09-19 DE DE19534649A patent/DE19534649A1/de not_active Withdrawn
-
1996
- 1996-09-13 AT AT96114713T patent/ATE181730T1/de not_active IP Right Cessation
- 1996-09-13 DE DE59602321T patent/DE59602321D1/de not_active Expired - Fee Related
- 1996-09-13 EP EP96114713A patent/EP0764637B1/de not_active Expired - Lifetime
- 1996-09-13 ES ES96114713T patent/ES2135145T3/es not_active Expired - Lifetime
- 1996-09-13 DK DK96114713T patent/DK0764637T3/da active
- 1996-09-16 US US08/715,270 patent/US5714514A/en not_active Expired - Lifetime
- 1996-09-17 IL IL11925696A patent/IL119256A/en not_active IP Right Cessation
- 1996-09-17 AU AU65664/96A patent/AU709499B2/en not_active Ceased
- 1996-09-18 ZA ZA967873A patent/ZA967873B/xx unknown
- 1996-09-18 MX MX9604158A patent/MX9604158A/es unknown
- 1996-09-18 CA CA002185850A patent/CA2185850A1/en not_active Abandoned
- 1996-09-18 JP JP8245830A patent/JPH09132560A/ja not_active Abandoned
-
1999
- 1999-08-18 GR GR990402059T patent/GR3030981T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US5714514A (en) | 1998-02-03 |
| EP0764637B1 (de) | 1999-06-30 |
| IL119256A (en) | 2001-07-24 |
| AU6566496A (en) | 1997-03-27 |
| IL119256A0 (en) | 1996-12-05 |
| JPH09132560A (ja) | 1997-05-20 |
| DK0764637T3 (da) | 1999-11-22 |
| CA2185850A1 (en) | 1997-03-20 |
| DE59602321D1 (de) | 1999-08-05 |
| ES2135145T3 (es) | 1999-10-16 |
| EP0764637A2 (de) | 1997-03-26 |
| AU709499B2 (en) | 1999-09-02 |
| GR3030981T3 (en) | 1999-12-31 |
| MX9604158A (es) | 1997-08-30 |
| EP0764637A3 (enExample) | 1997-04-16 |
| DE19534649A1 (de) | 1997-03-20 |
| ATE181730T1 (de) | 1999-07-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UA41358C2 (uk) | Похідні імідазопіридинів, спосіб їх одержання, фармацевтичний склад та спосіб його одержання | |
| PL324795A1 (en) | Application of adamantane derivatives in treating internal ear diseases | |
| GR3019272T3 (en) | 3,5-di-tertiarybutyl-4-hydroxyphenylmethylene derivatives of 2-substituted thiazolidinones, oxazolidinones, and imidazolidinones as antiinflammatory agents | |
| ES8602707A1 (es) | Procedimiento para preparar 2-fenil-hexahidro-1,2,4-triazin-3,5-dionas substituidas | |
| ZA967873B (en) | 2-Cyano-3-mercaptocrotonamides | |
| DK0439265T3 (da) | Hidtil ukendte 1,3-dicarbonylforbindelser og anvendelse deraf | |
| HU9600914D0 (en) | 4-indolylpiperazinyl derivatives | |
| GR3033123T3 (en) | Tricyclic derivatives, their preparation, their use in the preparation of optically active or racemic colchicine, thiocolchicine and analogues or derivatives, and intermediates | |
| ATE222239T1 (de) | Substituierte-chinolinderivate, verfahren zu ihrer herstellung und ihre verwendung | |
| DE68906122D1 (de) | Verbindungen zur behandlung von harninkontinenz. | |
| FI883759A0 (fi) | C.12-modifierade etromycin a-derivat. | |
| ES2053612T3 (es) | Agentes para la proteccion contra enfermedades de las plantas. | |
| ES8604894A1 (es) | Procedimiento para la obtencion de fluoralcoxifenilsulfonil-guanidinas | |
| AU3748697A (en) | 2-cyano-3, 5-dihydroxyhex-2-enecarboxamide derivatives | |
| ZA966832B (en) | Substituted 4H-pyrans. | |
| UA27025A1 (uk) | Гербіцидhий засіб і спосіб боротьби з бур'яhами | |
| ES8609254A1 (es) | Un procedimiento para preparar un derivado de piridinodicar-boxilato | |
| DK0758647T3 (da) | Acylsubstituerede aminopyraner med en modulerende virkning på kaliumkanaler | |
| ES8800885A1 (es) | Procedimiento mejorado de preparacion de derivados de estireno substituido | |
| IT1069996B (it) | Imidazoisoindoldioni sostituiti utili in particolare come diserbanti e realtivo procedimento di produzione | |
| ES459475A1 (es) | Procedimiento para la preparacion de nuevas 9-alcohilamino- eritromicina. | |
| IT1218886B (it) | Composto a base di 1-tia-3-aza-4-oni sostituiti | |
| ES459473A1 (es) | Procedimiento para la preparacion de nuevas 9-alcohilamino- eritromicinas. | |
| ATE56004T1 (de) | Triazinderivat, seine herstellung und verwendung. |